Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by hmmmmmmmmon Oct 31, 2023 5:32pm
147 Views
Post# 35710082

RE:RE:Mayo Clinic

RE:RE:Mayo ClinicOn the official ClinicalTrials.gov site the Mayo Clinic is not listed as a trial site for the Tigris trial.

There are 15 sites listed as "Recruiting" with another 4 listed as "Withdrawn" or
 "Terminated". The Mayo clinic is not mentioned. (Link below)

I probably wouldn't give it much thought if it wasn't the same company that fed us a couple years of trial misinformation on Dialco trials... before the "POOF" 

https://clinicaltrials.gov/study/NCT03901807?cond=Sepsis&intr=pmx&rank=3
<< Previous
Bullboard Posts
Next >>